Carl June, MD
Enriched profileRichard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director, Center for Cellular Immunotherapies; Director, Parker Institute for Cancer Immunotherapy · University of Pennsylvania
Carl June is Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director, Center for Cellular Immunotherapies; Director, Parker Institute for Cancer Immunotherapy at University of Pennsylvania. OpenAlex indexes 1,422 publications with 148,784 citations (h-index 179); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Medical Oncology profiles in the findmyKOL directory. Clarivate lists Carl June as a Highly Cited Researcher (Biology and Biochemistry, 2021-2025; Clinical Medicine, 2019-2025).
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Carl June, MD, is Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine at University of Pennsylvania, Perelman School of Medicine. The public record shows 1,422 publications with 148,784 citations (h-index 179), centered on CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 11 companies, 20 NIH-funded awards (2004–2026).
- Most recent indexed publication: 2026 · The New England journal of medicine
- Top research focus: CAR-T cell therapy research
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 106 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 656.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma
Sponsor: University of Pennsylvania
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment$8,978,680openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Gilead Sciences, Inc.Program year20252 payments
NIH funding
Updated 27 Aug 2026
20 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
University of Pennsylvania
FY2026$4,316,508U01AI163087 - Precision UCART and Nanoparticle Combination to Combat Hostile Microenvironments (PUNCH)
University of Pennsylvania
FY2026$673,026R01CA316019 - Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
University of Pennsylvania
FY2025$4,303,502U01AI163087
Congress activity
Updated 27 Aug 2026
113 congress contributions (2005–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Abstract 4806: CAR binders affect CAR T cell tonic signaling, durability, and sensitivity to target
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.
The New England journal of medicine
Clinical Trial2026 - HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack.
Blood advances
Article2026 - Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.
The New England journal of medicine
Clinical Trial2026 - CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.
Blood advances
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia5,419 citations2014
- 03Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia3,545 citations2011
- 04Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia3,498 citations2013
- 05Cytokine Storm3,186 citations2020
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/carl-june-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/carl-june-69402823b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Carl-June
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/university-of-pennsylvania-health-system_carl-june-breakthrough-prize-2024-activity-7108078082413977600-RB6B
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/university-of-pennsylvania-health-system_dr-carl-june-pioneer-in-car-t-cell-immunotherapy-activity-7162932301629227008-ZHAv
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/university-of-pennsylvania_carl-june-on-the-boundless-potential-of-car-activity-7103772316152553472-wTY1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- Board Certified
Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Center for Cellular Immunotherapies, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Director
Parker Institute for Cancer Immunotherapy, Penn Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkerici.org ↗ - Member
American Philosophical Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Biology and Biochemistry20212022202320242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Clinical Medicine2019202020212022202320242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine
Perelman School of Medicine, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗ - Director
Parker Institute for Cancer Immunotherapy at Penn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkerici.org ↗
Media & interviews
press, podcasts and appearances- "From CAR T-Cell Therapy to the Impact of Mentorship with Carl June, MD"
From Bench to Fireside podcast
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usnews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Corey Langer, MD
University of Pennsylvania